Journal of Urgent Care Medicine

No Causal Link to Autism or ADHD Found In Prenatal Opioid Exposure

A large Swedish study that examined prenatal exposure to prescribed opioid pain medications and the child’s risk of later developing autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD) found no causal link between prescribed opioid use during pregnancy and risk of the conditions. As published in PLOS Medicine, researchers analyzed data from more than 1.2 million children for ASD (2007–2018) and more than 900,000 children for ADHD (2007–2015). By the time the subjects were 10 …

ADHD Stimulants Present Risk of Weight Loss in Young Children

The Food and Drug Administration (FDA) has announced updates to the labeling of all extended-release stimulant medications indicated for attention-deficit/hyperactivity disorder (ADHD) because of a known risk of significant weight loss in children under 6 years of age. Clinically significant weight loss (at least a 10% decrease in the Centers for Disease Control and Prevention weight percentile) was observed in both short- and long-term studies with extended-release stimulants. The revised labeling will apply to extended-release …

Login to JUCM